Fuller Albright coined the term “pseudohypoparathyroidism” to describe hypoparathyroidism caused by target-organ resistance to the action of parathyroid hormone, as opposed to a simple deficiency of the hormone.1 The resistance to parathyroid hormone in pseudohypoparathyroidism Type I is thought to be due to a defect in the hormone receptor-adenylate cyclase complex, since patients with this disorder do not have the brisk rise in urinary cyclic AMP excretion that normally follows administration of parathyroid hormone.2 (Pseudohypoparathyroidism Type II is a much rarer disorder in which the urinary cyclic AMP response is normal but the phosphaturic response is defective.3) These were.
|Original language||English (US)|
|Number of pages||3|
|Journal||New England Journal of Medicine|
|State||Published - Sep 9 1982|
ASJC Scopus subject areas